Prescription Drug Companies Pay Big to Keep Shady Dealings and Health Insurance Costs Out of the Spotlight
Start here... |
| Select Insurance Type: |
| Zip code: |
|
|
Well, they paid billions anyway - $4.85 billion to be exact - in order to end lawsuits pertaining to allegations that they downplayed cardiovascular risks caused by the popular drug Vioxx in direct-to-consumer advertisements dating back to 1999.
Consumers shelled-out billions of dollars for the designer drug Vioxx, though safer alternatives were covered by almost all health insurance policies in the form of generics.
According to Kaiser's Daily Report, Merck is also required to end their policy of ghostwriting studies related to their drugs, and then passing them off as having been written by doctors.
Which was one more way that consumers were convinced to purchase these drugs, even when they weren't really that safe, and their health insurance didn't cover it.
Last year, as more and more consumers leaned towards generic drugs, prescription drug companies lost a lot of revenue. But, when so many health insurance policies cover generics, which have been around a long time and aren't likely to have any unknown effects, it just makes sense to save money and avoid the kind of dangerous side effects associated with new and controversial medications.













